ArticleThe oncologist2025
Pathomic immune biomarkers define recurrence risk in early-stage melanoma.
Thazin Nwe Aung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe oncologist2025
Thazin Nwe Aung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.